Krisanapan, P.; Sanpawithayakul, K.; Pattharanitima, P.; Thongprayoon, C.; Miao, J.; Mao, M.A.; Suppadungsuk, S.; Tangpanithandee, S.; Craici, I.M.; Cheungpasitporn, W.
Safety and Efficacy of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus with Advanced and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis. Diseases 2024, 12, 14.
https://doi.org/10.3390/diseases12010014
AMA Style
Krisanapan P, Sanpawithayakul K, Pattharanitima P, Thongprayoon C, Miao J, Mao MA, Suppadungsuk S, Tangpanithandee S, Craici IM, Cheungpasitporn W.
Safety and Efficacy of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus with Advanced and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis. Diseases. 2024; 12(1):14.
https://doi.org/10.3390/diseases12010014
Chicago/Turabian Style
Krisanapan, Pajaree, Kanokporn Sanpawithayakul, Pattharawin Pattharanitima, Charat Thongprayoon, Jing Miao, Michael A. Mao, Supawadee Suppadungsuk, Supawit Tangpanithandee, Iasmina M. Craici, and Wisit Cheungpasitporn.
2024. "Safety and Efficacy of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus with Advanced and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis" Diseases 12, no. 1: 14.
https://doi.org/10.3390/diseases12010014
APA Style
Krisanapan, P., Sanpawithayakul, K., Pattharanitima, P., Thongprayoon, C., Miao, J., Mao, M. A., Suppadungsuk, S., Tangpanithandee, S., Craici, I. M., & Cheungpasitporn, W.
(2024). Safety and Efficacy of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus with Advanced and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis. Diseases, 12(1), 14.
https://doi.org/10.3390/diseases12010014
